Skip to main content
Industry Posters

Reduced Psychosocial Burden and High Patient Satisfaction Associated With Glabellar Lines Treatment With LetibotulinumtoxinA: BLESS Phase 3 Trials

Music City SCALE 2026

Michael H. Gold, MD

This browser does not support PDFs. Please download the PDF to view it: Download PDF.